Table I.
Frequently used immune checkpoint inhibitors and their molecular targets.
Molecular target | Generic drug name | Brand name |
---|---|---|
PD-1 | Pembrolizumab | Keytruda |
Nivolumab | Opdivo | |
PD-L1 | Atezolizumab | Tecentriq |
Durvalumab | Imfinzi | |
Avelumab | Bavencio | |
CTLA-4 | Ipilimumab | Yervoy |
PD-1, programmed cell death-1; PD-L1, programmed cell death-ligand 1; CTLA-4, cytotoxic T-lymphocyte-associated protein-4.